Index RUT
P/E 78.02
EPS (ttm) 1.34
Insider Own 1.79%
Shs Outstand 14.99M
Perf Week 3.91%
Market Cap 1.58B
Forward P/E 33.83
EPS next Y 3.09
Insider Trans -4.60%
Shs Float 14.80M
Perf Month -0.48%
Income 18.14M
PEG 10.27
EPS next Q 0.56
Inst Own 103.61%
Short Float 4.19%
Perf Quarter 10.78%
Sales 604.80M
P/S 2.60
EPS this Y 8.42%
Inst Trans -3.15%
Short Ratio 8.67
Perf Half Y 26.13%
Book/sh 31.77
P/B 3.29
EPS next Y 11.33%
ROA 1.89%
Short Interest 0.62M
Perf Year -1.73%
Cash/sh 10.14
P/C 10.31
EPS next 5Y 7.60%
ROE 4.58%
52W Range 78.08 - 124.11
Perf YTD 12.24%
Dividend Est. 1.76 (1.68%)
P/FCF 21.43
EPS past 5Y -0.50%
ROI 2.62%
52W High -15.77%
Beta 1.42
Dividend TTM 1.29 (1.23%)
Quick Ratio 2.28
Sales past 5Y 6.41%
Gross Margin 18.52%
52W Low 33.89%
ATR (14) 2.40
Dividend Ex-Date Nov 15, 2023
Current Ratio 2.28
EPS Y/Y TTM -40.64%
Oper. Margin 11.50%
RSI (14) 54.70
Volatility 1.73% 2.49%
Employees 6720
Debt/Eq 0.54
Sales Y/Y TTM 9.34%
Profit Margin 3.00%
Recom 1.33
Target Price 119.30
Option/Short Yes / Yes
LT Debt/Eq 0.45
EPS Q/Q -3313.39%
Payout 134.52%
Rel Volume 0.30
Prev Close 103.64
Sales Surprise 3.03%
EPS Surprise 4.22%
Sales Q/Q 9.65%
Earnings May 07 AMC
Avg Volume 71.52K
Price 104.54
SMA20 2.33%
SMA50 -0.24%
SMA200 6.81%
Trades
Volume 16,163
Change 0.87%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-22-23 Initiated
JP Morgan
Overweight
$108
Jun-30-23 Initiated
BofA Securities
Buy
$138
Dec-14-21 Upgrade
CJS Securities
Market Perform → Market Outperform
$120
Aug-06-21 Reiterated
Barrington Research
Outperform
$130 → $139
May-07-21 Upgrade
Barrington Research
Mkt Perform → Outperform
$130
May-03-21 Upgrade
Jefferies
Hold → Buy
$130 → $135
Feb-26-21 Downgrade
Barrington Research
Outperform → Mkt Perform
Jun-08-20 Reiterated
Barrington Research
Outperform
$84 → $95
Apr-30-20 Downgrade
Sidoti
Buy → Neutral
Mar-11-20 Upgrade
Sidoti
Neutral → Buy
$128
Feb-28-20 Reiterated
Barrington Research
Outperform
$130 → $120
Nov-08-19 Upgrade
Barrington Research
Mkt Perform → Outperform
Mar-08-19 Initiated
William Blair
Outperform
Nov-03-17 Downgrade
Barrington Research
Outperform → Mkt Perform
Sep-08-17 Upgrade
Sidoti
Neutral → Buy
Jul-03-17 Upgrade
Barrington Research
Mkt Perform → Outperform
$68
Mar-17-17 Downgrade
Barrington Research
Outperform → Mkt Perform
Nov-04-16 Upgrade
Barrington Research
Mkt Perform → Outperform
$61
Aug-05-16 Downgrade
Barrington Research
Outperform → Mkt Perform
May-06-16 Upgrade
Barrington Research
Mkt Perform → Outperform
$58
Show Previous Ratings
May-01-24 11:09AM
08:30AM
Apr-23-24 04:05PM
Apr-01-24 07:30AM
Mar-11-24 07:00AM
05:15PM
Loading…
Mar-08-24 05:15PM
Mar-05-24 10:10AM
Mar-01-24 04:41AM
(Thomson Reuters StreetEvents)
Feb-28-24 06:05PM
05:31PM
05:14PM
(Associated Press Finance)
04:45PM
Feb-21-24 10:00AM
Feb-18-24 06:09AM
Feb-05-24 04:30PM
08:25AM
Loading…
Jan-09-24 08:25AM
Dec-16-23 07:01AM
Dec-06-23 10:57PM
Dec-01-23 08:59AM
Nov-09-23 04:05PM
02:57PM
05:52AM
(Thomson Reuters StreetEvents)
Nov-07-23 06:28PM
(Associated Press Finance)
04:30PM
Nov-01-23 08:30AM
Oct-30-23 05:50PM
Oct-19-23 11:40AM
Oct-15-23 10:30AM
Oct-13-23 04:05PM
Oct-03-23 11:40AM
08:30AM
Loading…
Oct-02-23 08:30AM
Aug-16-23 04:05PM
Aug-12-23 08:07AM
Aug-10-23 02:01AM
01:37AM
(Thomson Reuters StreetEvents)
Aug-08-23 06:40PM
05:40PM
05:05PM
Aug-02-23 11:08AM
Aug-01-23 09:00AM
Jul-31-23 02:13PM
Jul-20-23 04:05PM
Jul-19-23 11:40AM
Jul-07-23 08:49AM
Jun-21-23 08:00PM
Jun-20-23 08:00AM
Jun-19-23 08:38AM
Jun-18-23 09:25AM
Jun-05-23 11:40AM
May-31-23 04:02PM
May-30-23 04:01PM
May-26-23 06:58AM
May-25-23 08:27AM
May-24-23 09:59PM
May-23-23 04:30PM
May-18-23 11:40AM
May-16-23 04:05PM
May-12-23 06:09AM
May-04-23 04:01PM
May-03-23 05:55PM
04:01PM
May-01-23 11:40AM
Apr-26-23 08:00PM
06:25PM
Apr-19-23 04:01PM
Apr-17-23 09:46AM
Apr-14-23 11:40AM
Apr-05-23 10:46AM
Mar-22-23 11:40AM
Mar-21-23 12:59PM
Mar-06-23 04:05PM
11:40AM
Mar-01-23 08:00AM
Feb-28-23 08:00AM
Feb-22-23 11:57PM
Feb-21-23 12:44PM
Feb-03-23 06:42AM
Jan-31-23 02:00PM
Jan-22-23 09:52AM
Jan-11-23 10:00AM
Jan-08-23 08:31AM
Jan-03-23 07:09AM
Dec-18-22 04:48PM
Dec-06-22 07:45AM
Nov-30-22 04:05PM
Nov-15-22 10:00AM
Nov-13-22 07:02AM
Nov-11-22 05:11AM
Nov-07-22 01:52PM
10:00AM
Nov-02-22 06:05PM
04:05PM
Nov-01-22 08:30AM
Oct-31-22 10:00AM
Oct-18-22 09:00AM
Oct-17-22 04:05PM
Oct-12-22 12:38PM
Oct-11-22 10:47AM
Oct-10-22 11:00AM
Oct-03-22 07:30AM
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the Physical Therapy Operations and Industrial Injury Prevention Services segments. The Physical Therapy Operations segment consists of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The Industrial Injury Prevention Services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The company was founded in 1990 and is headquartered in Houston, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Binstein Richard EVP Gen'l Counsel & Secretary Mar 13 '24 Sale 106.55 2,000 213,100 15,006 Mar 14 05:11 PM HENDRICKSON CAREY P Chief Financial Officer Mar 13 '24 Sale 107.28 1,800 193,103 21,186 Mar 14 05:23 PM HAM NANCY Director Mar 13 '24 Sale 107.89 500 53,945 860 Mar 14 04:21 PM Trier Clayton Director Mar 13 '24 Sale 107.00 400 42,800 7,000 Mar 14 05:05 PM REEVE GRAHAM D. COO Mar 04 '24 Sale 104.39 2,629 274,441 6,902 Mar 05 06:28 PM KUNTZ EDWARD L Director Mar 04 '24 Sale 104.26 2,500 260,650 5,780 Mar 05 06:10 PM Williams Eric Joseph Co-Chief Operations Officer Mar 04 '24 Sale 104.96 1,500 157,440 19,314 Mar 05 06:15 PM Trier Clayton Director Dec 13 '23 Sale 92.26 1,170 107,944 7,400 Dec 14 05:09 PM REEVE GRAHAM D. COO Nov 15 '23 Sale 87.39 1,500 131,085 7,801 Nov 16 05:42 PM Gilmartin Kathleen A Director Nov 10 '23 Buy 82.34 1,000 82,340 15,480 Nov 13 07:09 PM Binstein Richard EVP Gen'l Counsel & Secretary Aug 15 '23 Sale 106.60 1,000 106,600 8,906 Aug 16 04:31 PM HAM NANCY Director Aug 15 '23 Sale 105.81 240 25,394 1,360 Aug 16 04:32 PM KUNTZ EDWARD L Director Aug 14 '23 Sale 107.60 1,000 107,600 8,280 Aug 14 05:07 PM REEVE GRAHAM D. COO Aug 11 '23 Sale 109.99 4,114 452,499 7,577 Aug 14 04:59 PM KUNTZ EDWARD L Director Aug 11 '23 Sale 109.95 1,000 109,950 9,280 Aug 14 05:07 PM
Index -
P/E 671.61
EPS (ttm) 0.01
Insider Own 88.69%
Shs Outstand 18.57M
Perf Week 0.46%
Market Cap 77.41M
Forward P/E -
EPS next Y -
Insider Trans 0.03%
Shs Float 2.10M
Perf Month -0.62%
Income 0.12M
PEG -
EPS next Q -
Inst Own 3.81%
Short Float 0.26%
Perf Quarter 2.31%
Sales 73.11M
P/S 1.06
EPS this Y -
Inst Trans 20.83%
Short Ratio 1.23
Perf Half Y 0.34%
Book/sh 3.33
P/B 1.25
EPS next Y -
ROA 0.14%
Short Interest 0.01M
Perf Year 28.92%
Cash/sh 0.29
P/C 14.42
EPS next 5Y -
ROE 0.21%
52W Range 3.02 - 6.40
Perf YTD 0.34%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI 0.18%
52W High -34.94%
Beta 0.76
Dividend TTM -
Quick Ratio 1.26
Sales past 5Y 19.53%
Gross Margin 14.11%
52W Low 37.88%
ATR (14) 0.11
Dividend Ex-Date -
Current Ratio 1.28
EPS Y/Y TTM 103.73%
Oper. Margin -3.52%
RSI (14) 53.15
Volatility 1.07% 2.56%
Employees 104
Debt/Eq 0.16
Sales Y/Y TTM -29.85%
Profit Margin 0.17%
Recom 1.00
Target Price 9.00
Option/Short No / Yes
LT Debt/Eq 0.13
EPS Q/Q 520.88%
Payout 0.00%
Rel Volume 1.37
Prev Close 4.15
Sales Surprise 14.84%
EPS Surprise 200.00%
Sales Q/Q -39.00%
Earnings May 07 AMC
Avg Volume 4.39K
Price 4.16
SMA20 1.46%
SMA50 0.99%
SMA200 -4.86%
Trades
Volume 4,473
Change 0.34%
Apr-30-24 08:30AM
Apr-24-24 08:30AM
Apr-03-24 08:30AM
Mar-08-24 08:38AM
Mar-06-24 10:51PM
05:05PM
Loading…
05:05PM
Feb-22-24 08:00AM
Nov-14-23 08:55AM
Nov-13-23 10:01AM
Nov-08-23 07:27PM
Oct-31-23 08:00AM
Oct-24-23 09:00AM
Aug-09-23 05:20PM
Jul-27-23 08:00AM
Jun-12-23 05:00PM
04:15PM
Loading…
May-10-23 04:15PM
Apr-26-23 04:00PM
Mar-08-23 05:40PM
Feb-23-23 05:10PM
Nov-02-22 07:45PM
Oct-20-22 08:30AM
Sep-21-22 08:00AM
Sep-13-22 09:00AM
Aug-10-22 05:00PM
Jul-28-22 08:00AM
Jun-11-22 08:28AM
May-04-22 06:30PM
Apr-20-22 08:30AM
Apr-04-22 07:30AM
Mar-22-22 08:00AM
06:00PM
Loading…
Mar-09-22 06:00PM
Mar-01-22 04:15PM
Dec-17-21 09:55AM
Nov-10-21 05:15PM
Oct-21-21 08:00AM
Oct-07-21 04:30PM
Sep-21-21 08:00AM
Sep-16-21 07:00AM
Aug-23-21 11:37AM
Aug-04-21 05:30PM
Aug-03-21 07:00AM
Jul-27-21 11:25AM
Jun-28-21 02:30PM
Jun-01-21 04:58PM
May-27-21 07:15PM
May-26-21 07:00AM
May-18-21 05:30PM
May-05-21 05:24PM
May-04-21 03:13PM
Apr-29-21 01:18PM
Apr-28-21 07:00AM
Apr-26-21 07:00AM
Apr-20-21 07:30AM
Apr-13-21 07:00AM
Stabilis Solutions, Inc. engages in the provision of small-scale liquefied natural gas production, distribution, and fueling services to multiple end markets. It operates through the following segments: LNG and Power Delivery. The LNG segment supplies LNG to the industrial, midstream, and oilfield sectors in North America and provides turnkey fuel solutions to help users of propane, diesel and other crude-based fuel products convert to LNG. The Power Delivery segment provides power delivery solutions to the global energy industry through its subsidiary in Brazil and joint venture in China. The company was founded on October 21, 1996 and is headquartered in Houston, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KUNTZ EDWARD L Director Nov 13 '23 Buy 4.91 5,000 24,550 58,172 Nov 14 08:45 AM Ballard Westervelt T. JR President and CEO Aug 23 '23 Option Exercise 0.00 125,000 0 432,916 Aug 25 04:46 PM KUNTZ EDWARD L Director May 26 '23 Buy 3.87 7,000 27,090 53,172 May 30 04:13 PM Morris Matthew Director May 17 '23 Buy 3.51 3,866 13,553 16,000 May 18 04:01 PM Morris Matthew Director May 16 '23 Buy 3.36 4,134 13,872 12,134 May 18 04:01 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite